Abstract | BACKGROUND: STUDY DESIGN: We compared patients with advanced appendicitis (gangrenous or perforated) treated with 1,000 mg MP every eight hours with those given the combination of tobramycin 5 mg/kg/day at eight hour intervals and clindamycin 900 mg every eight hours. Both treatments were given intravenously. Patients were randomized to either group of the double-blind study. RESULTS: Of 129 evaluable cases, 63 received MP and 66 received both tobramycin and clindamycin (T/C). The two groups were similar in age, sex, and severity of disease. The mean number of days of postoperative fever (MP = 3.1 +/- 1.7 SD compared to T/C = 4.4 +/- 2.2 SD, p < or = 0.01), days of antibiotic therapy (MP = 6.1 +/- 1.6 SD compared to T/C = 7.3 +/- 2.2 SD, p = 0.01), and therefore hospital stay (MP = 8.0 +/- 3.5 SD compared to T/C = 9.4 +/- 2.6 SD, p < 0.01) were significantly better for patients treated with MP. No difference was found between the numbers of failures in each group (MP = 5 compared to T/C = 6). CONCLUSIONS: This study demonstrates a small but significant reduction (approximately one day) in post-operative fever, duration of antibiotic treatment, and hospital stay for patients treated with MP compared to those treated with T/C.
|
Authors | T V Berne, A E Yellin, M D Appleman, P N Heseltine, M A Gill |
Journal | Journal of the American College of Surgeons
(J Am Coll Surg)
Vol. 182
Issue 5
Pg. 403-7
(May 1996)
ISSN: 1072-7515 [Print] United States |
PMID | 8620275
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Thienamycins
- Clindamycin
- Meropenem
- Tobramycin
|
Topics |
- Adult
- Anti-Bacterial Agents
(administration & dosage, therapeutic use)
- Appendicitis
(drug therapy)
- Clindamycin
(administration & dosage, therapeutic use)
- Double-Blind Method
- Drug Administration Schedule
- Drug Therapy, Combination
(administration & dosage, therapeutic use)
- Female
- Humans
- Intestinal Perforation
(drug therapy)
- Length of Stay
- Male
- Meropenem
- Rupture, Spontaneous
- Thienamycins
(therapeutic use)
- Time Factors
- Tobramycin
(administration & dosage, therapeutic use)
|